Biotech Industry

 
News Articles for Biotech Industry top ^
http://media.marketwire.com/attachments/201409/78832_contrafect.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145877&ProfileId=051205&sourceType=1 YONKERS, NEW YORK --
Sign-up for ContraFect Corporation to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 21 st Annual NewsMakers in the Biotech Industry Conference on Friday, September 26, 2014 at 1:30 p.m. ET at the Millennium Broadway Hotel in New York City.
Sign-up for Alnylam to Webcast Presentation at 21st Annual NewsMakers in the Biotech Industry Conference investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead’s chief operating officer, will present at BioCentury’s 21 st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30 a.m. EDT in New York.
Sign-up for Arrowhead to Present at BioCentury’s NewsMakers in the Biotech Industry Conference investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) , a clinical-stage biopharmaceutical company whose lead product candidate, eravacycline, is being developed as a broad-spectrum intravenous and oral antibiotic designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced that Guy Macdonald, Tetraphase President and Chief Executive Officer , will present at BioCentury’s 2014 NewsMakers in the Biotech Industry Conference on Friday, September 26 th at 2:30 p.m. Eastern Time.
Sign-up for Tetraphase Pharmaceuticals to Present at BioCentury’s 2014 NewsMakers in the Biotech Industry Conference investment picks
Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer of Fibrocell Science will present at the BioCentury NewsMakers in the Biotech Industry conference at 9:30 a.m. EDT on Friday, September 26, 2014, in New York City.
Sign-up for Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry Conference investment picks
Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that management will present a company overview at the BioCentury 21 st Annual NewsMakers in the Biotech Industry Conference.
Sign-up for Genocea to Present at the 21st Annual NewsMakers in the Biotech Industry Conference investment picks
Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced the Company will present at the BioCentury NewsMakers in the Biotech Industry Conference in New York City, N.Y. The presentation will take place on Friday, September 26 at 8:30 a.m. Eastern Time, when Tim M.
Sign-up for Esperion Therapeutics to Present at BioCentury’s NewsMakers in the Biotech Industry Conference investment picks
2014/9/22
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the NewsMakers in the Biotech Industry conference at 2:30 PM EDT, Friday, September 26, at the Millennium Broadway Hotel in New York City.
Sign-up for EPIRUS to Present at NewsMakers in the Biotech Industry Conference investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for Radius Health to Present at the BioCentury NewsMakers in the Biotech Industry Conference investment picks
http://media.marketwire.com/attachments/200501/200497_SciCloneLogo-Color-R.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145120&ProfileId=051205&sourceType=1 FOSTER CITY, CA --
Sign-up for SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014 investment picks
MENLO PARK, Calif., Sept.
Sign-up for Avalanche Biotechnologies to Present at the NewsMakers in the Biotech Industry Conference investment picks
BERKELEY HEIGHTS, N.J., Sept.
Sign-up for Cyclacel to Present at BioCentury's Newsmakers in the Biotech Industry Conference investment picks
LOS ANGELES , Sept.
Sign-up for CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference investment picks
REDWOOD CITY, Calif., Sept.
Sign-up for Relypsa to Present at Newsmakers in the Biotech Industry investment picks
Presentation and Webcast Scheduled for September 26th at 3:30 PM ET LOS ANGELES , Sept.
Sign-up for CytRx Updates Presentation Time at BioCentury's 2014 NewsMakers in the Biotech Industry Conference investment picks
http://media.marketwire.com/attachments/201404/74157_horizonpharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146042&ProfileId=051205&sourceType=1 DUBLIN, IRELAND --
Sign-up for Horizon Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Conference investment picks
GAITHERSBURG, Md., Sept.
Sign-up for GlycoMimetics to Present at BioCentury's 21st Annual Newsmakers in the Biotech Industry Conference investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Biotech Industry
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Biotech Companies  |  Next: Biotech Industry Conference